Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £6,383 | £4,903 | £4,646 | £9,744 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £0 | £0 | £0 | £0 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £1,214 | £1,606 | £1,340 | £1,681 |
| Total Curr. Assets | £7,597 | £6,510 | £5,985 | £11,425 |
| Property Plant & Equip (Net) | £19 | £25 | £36 | £18 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £2,341 | £2,261 | £2,261 | £2,261 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | -£2,286 | -£2,297 | -£2,280 |
| Total NC Assets | £2,361 | £2,286 | £2,297 | £2,280 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £9,957 | £8,796 | £8,283 | £13,705 |
| Liabilities | – | – | – | – |
| Payables | £395 | £173 | £218 | £726 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £70 | £80 | £82 | £49 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £303 | £917 | £473 | £494 |
| Total Curr. Liab. | £768 | £1,170 | £773 | £1,268 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £768 | £1,170 | £773 | £1,268 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £953 | £733 | £599 | £598 |
| Retained Earnings | -£31,332 | -£26,151 | -£20,181 | -£15,247 |
| AOCI | £0 | £0 | £0 | £0 |
| Other Equity | £39,569 | £33,044 | £27,091 | £27,086 |
| Total Equity | £9,189 | £7,626 | £7,509 | £12,436 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £9,957 | £8,796 | £8,283 | £13,705 |
| Net Debt | -£6,383 | -£4,903 | -£4,646 | -£9,744 |